Salidroside also reduced lung inflammation and alleviated ALI symptoms by upregulating Sirt1 expression and inhibiting both NF-κB activity and nucleocytoplasmic translocation of HMGB1 both in vivo and in vitro (Lan et al., 2017; Qi et al., 2017). This evidence concerns the gene NFKB1 and acute respiratory distress syndrome.